Related Experiment Video
Updated: Jun 19, 2026
05:28
Application of a Dual Upper Limb Task-Oriented Robotic System for the Functional Recovery of the Upper Limb in Stroke Patients
Published on: October 11, 2024
Constraint-induced movement therapy for upper extremities in stroke patients
Valeria Sirtori1, Davide Corbetta, Lorenzo Moja
1Unita Operativa di Recupero e Rieducazione Funzionale, Fondazione Centro San Raffaele del Monte Tabor, via Olgettina, 58, Milan, Lombardia, Italy, 20132.
The Cochrane Database of Systematic Reviews
|October 13, 2009
Summary
Constraint-induced movement therapy (CIMT) moderately reduces disability in stroke patients immediately after treatment. However, benefits for arm function and disability do not persist long-term, indicating a need for further research.
Area of Science:
- Neurology
- Rehabilitation Medicine
- Physical Therapy
Background:
- Upper limb paresis is a common and disabling consequence of stroke, significantly impacting daily activities.
- Effective rehabilitation strategies are crucial for improving functional outcomes in hemiparetic patients.
- Constraint-induced movement therapy (CIMT) is a rehabilitation approach involving forced use of the affected arm and restraint of the unaffected arm.
Purpose of the Study:
- To evaluate the effectiveness of CIMT, modified CIMT (mCIMT), and forced use (FU) interventions for improving arm function in stroke survivors with hemiparesis.
- To synthesize evidence from randomized controlled trials (RCTs) and quasi-RCTs (qRCTs) on the efficacy of these therapies.
Main Methods:
- A systematic review and meta-analysis was conducted, searching multiple databases including Cochrane Stroke, CENTRAL, MEDLINE, EMBASE, CINAHL, and PEDro up to June 2008.
- Included studies were RCTs and qRCTs comparing CIMT, mCIMT, or FU against other rehabilitation techniques or no intervention.
- Data extraction and quality assessment were performed independently by two reviewers, with disability as the primary outcome measure.
Main Results:
- Nineteen studies involving 619 participants were included. Most studies were underpowered and had suboptimal allocation concealment.
- A moderate, statistically significant reduction in disability was observed immediately post-intervention (SMD 0.36, 95% CI 0.06 to 0.65).
- Arm motor function showed a significant improvement (SMD 0.72, 95% CI 0.32 to 1.12), but no significant long-term benefits in disability were found in follow-up assessments.
Conclusions:
- CIMT and related therapies demonstrate a moderate short-term benefit in reducing disability and improving arm motor function in hemiparetic stroke patients.
- The observed benefits do not appear to persist several months after the cessation of treatment.
- Further high-quality RCTs with larger sample sizes and extended follow-up periods are warranted to confirm these findings and explore long-term efficacy.
